• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

粪便血红蛋白定量免疫化学检测(FIT)的检测能力及低粪便血红蛋白浓度报告。

Detection capability of quantitative faecal immunochemical tests for haemoglobin (FIT) and reporting of low faecal haemoglobin concentrations.

机构信息

Centre for Research into Cancer Prevention and Screening, University of Dundee, Ninewells Hospital and Medical School, Dundee DD1 9SY, Scotland, UK.

NHS Bowel Cancer Screening Programme, Southern Hub, Royal Surrey County Hospital NHS Foundation Trust, Guildford, Surrey, UK.

出版信息

Clin Chem Lab Med. 2019 Apr 24;57(5):611-616. doi: 10.1515/cclm-2018-0464.

DOI:10.1515/cclm-2018-0464
PMID:29995629
Abstract

Faecal immunochemical tests for haemoglobin (FIT) are widely used in asymptomatic population screening for colorectal (bowel) cancer. FIT are also used to assist with the assessment of patients presenting with lower abdominal symptoms. Quantitative FIT allow the generation of numerical estimates of faecal haemoglobin (f-Hb) concentrations. There is now great interest in "low" f-Hb concentrations in these clinical settings: in consequence, knowledge of the detection capability is very important for f-Hb concentration examinations. There are a number of current problems associated with the reporting of low f-Hb concentrations and wide misunderstanding of the metrological aspects of examinations of f-Hb at low concentrations. These would be solved if the detectability characteristics of f-Hb concentration examinations, namely, the limit of blank (LoB), limit of detection (LoD) and limit of quantitation (LoQ), were generated, validated and used in reporting systems exactly as recommended in the EP17-A2 guideline of the Clinical Laboratory Standards Institute. LoB and LoD are statistical concepts, but the LoQ depends on definition of analytical performance specifications (APS). In this Opinion Paper proposals for interim APS are made, based on the current state of the art achieved with examinations of faecal samples. It is proposed that LoQ is determined at an examination imprecision of CV≤10% using faecal samples naturally positive for Hb rather than faeces spiked with haemolysate. Detailed proposals for reporting f-Hb data at low concentrations are also made.

摘要

粪便免疫化学检测血红蛋白(FIT)广泛应用于无症状人群的结直肠癌(肠道)筛查。FIT 也用于协助评估出现下腹部症状的患者。定量 FIT 可生成粪便血红蛋白(f-Hb)浓度的数值估计。目前,人们对这些临床环境中的“低”f-Hb 浓度非常感兴趣:因此,了解检测能力对于 f-Hb 浓度检测非常重要。目前,与低 f-Hb 浓度报告相关的问题有很多,并且对低浓度 f-Hb 检测的计量学方面存在广泛的误解。如果按照临床实验室标准协会 EP17-A2 指南中的建议,准确地在报告系统中生成、验证和使用 f-Hb 浓度检测的可检测特性(LoB、LoD 和 LoQ),就可以解决这些问题。LoB 和 LoD 是统计概念,但 LoQ 取决于分析性能规格(APS)的定义。在本意见书中,基于目前在粪便样本检测方面取得的最新技术水平,提出了临时 APS 的建议。建议在使用自然含有 Hb 的粪便样本而不是用溶血物处理的粪便样本,在 CV≤10%的检测精密度下确定 LoQ。还提出了详细的低浓度 f-Hb 数据报告建议。

相似文献

1
Detection capability of quantitative faecal immunochemical tests for haemoglobin (FIT) and reporting of low faecal haemoglobin concentrations.粪便血红蛋白定量免疫化学检测(FIT)的检测能力及低粪便血红蛋白浓度报告。
Clin Chem Lab Med. 2019 Apr 24;57(5):611-616. doi: 10.1515/cclm-2018-0464.
2
Setting up a service for a faecal immunochemical test for haemoglobin (FIT): a review of considerations, challenges and constraints.建立粪便血红蛋白免疫化学检测(FIT)服务:考虑因素、挑战和限制的回顾。
J Clin Pathol. 2018 Dec;71(12):1041-1045. doi: 10.1136/jclinpath-2018-205047. Epub 2018 Oct 1.
3
A comparison of the faecal haemoglobin concentrations and diagnostic accuracy in patients suspected with colorectal cancer and serious bowel disease as reported on four different faecal immunochemical test systems.比较四种不同粪便免疫化学检测系统报告的疑似结直肠癌和严重肠道疾病患者的粪便血红蛋白浓度和诊断准确性。
Clin Chem Lab Med. 2022 Jun 1;60(8):1278-1286. doi: 10.1515/cclm-2021-1248. Print 2022 Jul 26.
4
Faecal immunochemical tests (FIT) in the assessment of patients presenting with lower bowel symptoms: Concepts and challenges.粪便免疫化学检测(FIT)在评估下消化道症状患者中的应用:概念与挑战。
Surgeon. 2018 Oct;16(5):302-308. doi: 10.1016/j.surge.2018.01.004. Epub 2018 Mar 13.
5
Use of a faecal immunochemical test for haemoglobin can aid in the investigation of patients with lower abdominal symptoms.使用粪便免疫化学检测血红蛋白有助于对下腹部症状患者进行调查。
Clin Chem Lab Med. 2016 Apr;54(4):595-602. doi: 10.1515/cclm-2015-0617.
6
Does the mass of sample loaded affect faecal haemoglobin concentration using the faecal immunochemical test?使用粪便免疫化学检测时,所加载样本的质量会影响粪便血红蛋白浓度吗?
Ann Clin Biochem. 2018 Nov;55(6):702-705. doi: 10.1177/0004563218778701. Epub 2018 Jun 6.
7
Faecal haemoglobin concentration thresholds for reassurance and urgent investigation for colorectal cancer based on a faecal immunochemical test in symptomatic patients in primary care.基于粪便免疫化学试验在初级保健中有症状患者中用于结直肠癌的确认和紧急调查的粪便血红蛋白浓度阈值。
Ann Clin Biochem. 2021 May;58(3):211-219. doi: 10.1177/0004563220985547. Epub 2021 Jan 21.
8
Measurement of faecal haemoglobin with a faecal immunochemical test can assist in defining which patients attending primary care with rectal bleeding require urgent referral.粪便血红蛋白免疫检测可用于辅助确定哪些因直肠出血而到基层医疗机构就诊的患者需要紧急转介。
Ann Clin Biochem. 2020 Jul;57(4):325-327. doi: 10.1177/0004563220935622.
9
Diagnostic inconsistency of faecal immunochemical tests for haemoglobin in population screening of colorectal cancer.粪便血红蛋白免疫化学检测用于结直肠癌人群筛查的诊断不一致性。
Clin Chem Lab Med. 2013 Nov;51(11):2173-80. doi: 10.1515/cclm-2013-0232.
10
Service evaluation of faecal immunochemical testing and anaemia for risk stratification in the 2-week-wait pathway for colorectal cancer.粪便免疫化学检测和贫血用于结直肠癌 2 周等待路径风险分层的服务评估。
BJS Open. 2019 Jan 28;3(3):395-402. doi: 10.1002/bjs5.50131. eCollection 2019 Jun.

引用本文的文献

1
Combining faecal haemoglobin, iron deficiency anaemia status and age can improve colorectal cancer risk prediction in patients attending primary care with bowel symptoms: a retrospective observational study.结合粪便血红蛋白、缺铁性贫血状态和年龄可改善有肠道症状的基层医疗患者的结直肠癌风险预测:一项回顾性观察研究。
Gut. 2025 Aug 7;74(9):1430-1436. doi: 10.1136/gutjnl-2024-334248.
2
Changes in faecal haemoglobin values over sequential rounds of faecal immunochemical tests (FIT) in a surveillance population.监测人群中连续多轮粪便免疫化学检测(FIT)期间粪便血红蛋白值的变化。
BMJ Open Gastroenterol. 2025 Feb 11;12(1):e001651. doi: 10.1136/bmjgast-2024-001651.
3
Risk-stratified faecal immunochemical testing (FIT) for urgent colonoscopy in Lynch syndrome during the COVID-19 pandemic.
基于风险分层的粪便免疫化学检测(FIT)在 COVID-19 大流行期间用于林奇综合征的紧急结肠镜检查。
BJS Open. 2023 Sep 5;7(5). doi: 10.1093/bjsopen/zrad079.
4
Exploring the utility and acceptability of Faecal immunochemical testing (FIT) as a novel intervention for the improvement of colorectal Cancer (CRC) surveillance in individuals with lynch syndrome (FIT for lynch study): a single-arm, prospective, multi-centre, non-randomised study.探索粪便免疫化学检测(FIT)作为林奇综合征(FIT for Lynch 研究)个体结直肠癌(CRC)监测改善的新型干预措施的实用性和可接受性:一项单臂、前瞻性、多中心、非随机研究。
BMC Cancer. 2022 Nov 7;22(1):1144. doi: 10.1186/s12885-022-10217-y.
5
Faecal haemoglobin concentration in adenoma, before and after polypectomy, approaches the ideal tumour marker.腺瘤息肉切除术前和术后粪便血红蛋白浓度接近理想的肿瘤标志物。
Ann Clin Biochem. 2022 Jul;59(4):272-276. doi: 10.1177/00045632221080897. Epub 2022 Mar 2.
6
Evaluation of the Sentinel-FOB gold faecal immunochemical test for the presence of haemoglobin using the automated Roche Cobas 8000 system.使用罗氏Cobas 8000自动化系统评估Sentinel-FOB金标粪便免疫化学检测法检测血红蛋白的情况。
Pract Lab Med. 2022 Jan 15;29:e00263. doi: 10.1016/j.plabm.2022.e00263. eCollection 2022 Mar.
7
Faecal Haemoglobin Estimated by Faecal Immunochemical Tests-An Indicator of Systemic Inflammation with Real Clinical Potential.粪便免疫化学检测法估算的粪便血红蛋白——具有实际临床潜力的全身炎症指标
Diagnostics (Basel). 2021 Nov 12;11(11):2093. doi: 10.3390/diagnostics11112093.
8
Faecal haemoglobin concentrations in women and men diagnosed with colorectal cancer in a national screening programme.在国家筛查计划中诊断为结直肠癌的男性和女性的粪便血红蛋白浓度。
J Med Screen. 2022 Mar;29(1):26-31. doi: 10.1177/09691413211056970. Epub 2021 Nov 22.
9
The use of faecal haemoglobin in deciding which patients presenting to primary care require further investigation (and how quickly) - the FIT approach.利用粪便血红蛋白来确定哪些到初级保健机构就诊的患者需要进一步检查(以及检查的紧迫性)——粪便免疫化学检测方法。
EJIFCC. 2021 Feb 28;32(1):52-60. eCollection 2021 Feb.
10
Faecal immunochemical testing in bowel cancer screening: Estimating outcomes for different diagnostic policies.粪便免疫化学检测在结直肠癌筛查中的应用:不同诊断策略的结果评估。
J Med Screen. 2021 Sep;28(3):277-285. doi: 10.1177/0969141320980501. Epub 2020 Dec 20.